The global Infertility Treatment market is projected to reach USD 6.2 billion by 2030, growing at a CAGR of 12.4%
Factors that drive the growth of infertility treatment industry are occurrence of lifestyle disorders, declining fertility rates, increase in awareness amongst people regarding infertility, availability of options for treatment and developed technologies for devices used in infertility treatment. Expensive procedures and uncooperative regulations of government are the factors that are hindering the growth of infertility treatment market.
Infertility is a condition, detected in both women and men. The global infertility treatment industry includes devices, services and drugs given for the treatment of infertility. Infertility is caused by several reasons such as genetic problems, sexually transmitted infections and damage to DNA because of smoking, pollutants such as pesticides, glues and chemical dust. Smoking reduces fertility in men affecting their sperm count and affects oocytes in women. Therefore, various disorders are caused by smoking and lessening the fertility rate and this is one of the biggest factors boosting the growth of infertility treatment market across the world.
Healthcare industry is rapidly changing in the developing market because of rising amount of hospitals, the rise in the surgeries, rise in awareness regarding healthcare and increase in the expenditure by the government are offering the appropriate opportunities for increasing the infertility treatment market. For infertility treatment market in India, the government is spending more on the treatment of infertility.
Global infertility treatment market is segmented on the basis of products, procedures, patient type, end-user and regions. On the basis of products, infertility treatment industry is divided into equipment, accessories and media & consumables. Equipment segment hold the largest shares of global infertility treatment device market. On the basis of procedure, the market of infertility treatment is divided into artificial insemination (AI), assisted reproductive technology (ART), fertility surgeries and many more. Assisted reproductive technology holds the largest share in infertility treatment market.
Based on the patient type, infertility treatment market is segmented into female and male patients. The segment of female patients plays a major role in infertility treatment market share, because of reducing fertility rates in female and availability of options for treatment. On the basis of end-user, infertility treatment market is divided into cryobanks, research institutes, fertility centers and hospitals & clinics. Fertility centers hold the largest share because of increase in the medical visit and success rates of the centers of fertility. These reasons are fueling the growth of infertility treatment market.
Nowadays, infertility rate in men is increasing. Global male infertility treatment market is projected to increase rapidly because of environment effect, increased obesity, rise in consumption of drugs & alcohol, change in lifestyle and increase in the occurrence of cases of infertility. Male Infertility treatment market is divided into hormonal therapy, assisted reproductive technology and drugs. On the basis of hormonal therapy, male infertility treatment market is divided into Recombinant follicle stimulating hormone and Human chronic gonadotropin hormone. On the basis of assisted reproductive technology, the market is divided into gamete intrafallopian transfer (GIFT), zygote intrafallopian transfer (ZIFT), frozen embryo transfer (FET) and in-vitro fertilization embryo transfer (IVF-ET). Drugs are divided into tamoxifen & clomiphene citrate.
Geographically, regions focusing on the development of infertility treatment market are Europe, North America, Asia Pacific and Middle East & Africa. North America holds the maximum shares in terms of revenue in infertility treatment market, continued by the Asia Pacific and Europe.
Key company profile in the Global Infertility Treatment Market report are The Cooper Companies Inc. (US), Cook (US), Vitrolife (Sweden), Thermo Fisher Scientific, Inc. (US), Esco Micro Pte. Ltd. (Singapore), Genea Biomedx (Australia), IVFtech ApS (Denmark), FUJIFILM Irvine Scientific (US), The Baker Company, Inc. (US), Kitazato Corporation (Japan), Rocket Medical plc (UK), IHMedical A/S (Denmark), Hamilton Thorne Ltd. (US), Carl Zeiss AG (Germany), MedGyn Products, Inc. (US), DxNow, Inc. (US), Nidacon International AB (Sweden), Gynotec B.V. (Netherlands), SAR Healthline Pvt. Ltd. (India), and InVitroCare Inc. (US) among others.
Infertility Treatment Market Scope
|Forecast Unit||Value (USD)|
|Segment Covered||By Product, By Procedure, By Patient type, By End-user, Regions|
|Regions Covered||North America, Europe, Asia Pacific, South America, Middle East and South Africa|
Key segments of the Infertility Treatment Market.
by Diagnosis, 2022 to 2030 (USD Billion)
• Men Diagnostic Tests
• Women Diagnostic
• General Diagnostic Tests
by Techniques, 2022 to 2030 (USD Billion)
• Assisted Reproductive Technology
• Intrauterine Insemination, Surgery
By Product, 2022 to 2030 (USD Billion)
• Media & Consumables
By End-user, 2022 to 2030 (USD Billion)
• Research Institutes
• Fertility Centers
Region Overview, 2022 to 2030 (USD Billion)
• North America
o United States of America
o the Netherlands
o The United Kingdom
o Rest of Europe
o South Korea
o Rest of Asia-Pacific
• South America
o Rest of South America